Careers  |  Sign In  |  Register

Latest in Rheumatology

Reuters Health • The Doctor's Channel Daily Newscast

Zoledronic acid prevents bone loss in postmenopausal women with osteopenia

NEW YORK (Reuters Health) - In postmenopausal women with osteopenia, zoledronic acid, given either once-yearly or as a single infusion, is well tolerated and effective in preventing bone loss at the lumbar spine and proximal femur for up to 2 years. That’s according to randomized controlled trial...

Reuters Health • The Doctor's Channel Daily Newscast

Zoledronic acid may improve survival of lung cancer with bone metastases

NEW YORK (Reuters Health) – Treatment with the third generation bisphosphonate zoledronic acid (Zometa) may improve survival in lung cancer patients with bone metastases, Greek researchers report. Between 20% and 40% of lung cancer patients will have bone metastases, Dr. Nikos K. Karamanos, from the...

Reuters Health • The Doctor's Channel Daily Newscast

Risks of opioid use by elderly arthritic patients outweigh benefits

NEW YORK (Reuters Health) – Opioid analgesics should not be used in elderly patients with osteoarthritis even if their pain is severe, because the associated risks are so great, according to a review of previous studies. “We found that pain reduction with opioid treatment was small to moderate. ...